On what concerns breast cancer development, lower levels of NRF2 due to polymorphisms in NRF2 or KEAP1 alone or in association with polymorphisms in estrogen biosynthesis and metabolism might contribute to inefficient estrogen detoxification. This evidence concerns the gene KEAP1 and breast cancer.